Traffic Lights
Crizanlizumab
Status:
Unclassified
Decision Date:
None
Comments
NICE TA743:
for preventing sickle cell crises in sickle cell disease. (Decision date - Dec 2021). -
Guidance now withdrawn
(February 2024)
search again